PropertyValue
?:definition
  • A technique for enhancing cell-mediated immunity by either artificially increasing the number of specific immunocompetent cells through inoculation of ex-vivo expanded primarily activated cytotoxic lymphocytes, or genetically engineered lymphocytes with enhanced cytotoxic ability, or by altering tumor cells to make them more immunogenic. The concept does not refer to anticancer vaccines and immune modulation through the therapeutic use of cytokines, cell receptors, or other substances Check for \'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C15351\' active clinical trials using this agent. (\'http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C15351\' NCI Thesaurus)
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C0079613_PDQ>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C0079613_PDQ>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all